Multiple anti-apoptotic pathways stimulated by EGF in cytotrophoblasts

E D Johnstone1, M Mackova, S Das

  • 1Department of Medical Microbiology and Immunology, and the University of Alberta Perinatal Research Centre, Edmonton, Alberta, Canada.

Placenta
|July 5, 2005
PubMed

Insights

Epidermal growth factor (EGF) activates multiple pathways, including JNK and sphingosine kinase-1 (SPHK-1), to reduce cytotrophoblast (CT) apoptosis. These findings reveal novel survival signaling mechanisms in trophoblast cells.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Reproductive Biology

Background:

  • Epidermal growth factor (EGF) is known to reduce apoptosis in primary cytotrophoblast (CT) via extracellular signal-related kinase (ERK) 1/2 and phosphatidylinositol 3-kinase (PI-3 kinase) pathways.
  • The involvement of other signaling pathways in EGF-mediated survival signaling in CT cells remains largely unknown.

Purpose of the Study:

  • To investigate the role of c-Jun NH2-terminal kinase (JNK), mitogen-activated protein kinase p38 (MAPK p38), and sphingosine kinase-1 (SPHK-1) in EGF-induced survival signaling in primary CT cells.
  • To elucidate the interplay between these pathways and the known PI-3 kinase and ERK1/2 pathways in regulating CT apoptosis.

Main Methods:

  • Primary human cytotrophoblast (CT) cells were cultured.
  • EGF treatment was applied, followed by assessment of apoptosis.
  • Specific inhibitors were used to block JNK (SP600125), p38 (SB203580), SPHK-1 (dimethyl sphingosine, DMS), and PI-3 kinase (LY294002).
  • Western blotting was used to measure protein phosphorylation (JNK, p38, Akt, ERK1/2).
  • SPHK-1 activity was measured in response to EGF and LY294002 treatment.

Main Results:

  • EGF activated both JNK and p38 pathways, indicated by increased phosphorylation.
  • Inhibition of JNK increased CT apoptosis independently of EGF, while p38 inhibition did not affect apoptosis.
  • EGF activated SPHK-1, and its inhibition with DMS increased trophoblast death.
  • SPHK-1 inhibition did not affect EGF-stimulated phosphorylation of PI-3 kinase, Akt, ERK1/2, or p38.
  • PI-3 kinase inhibition partially reduced EGF-stimulated SPHK-1 activity.

Conclusions:

  • EGF stimulates CT survival through multiple pathways, including JNK and SPHK-1, in addition to PI-3 kinase and ERK1/2.
  • The JNK and SPHK-1 pathways, but not p38, are critical for mediating the anti-apoptotic effects of EGF in CT cells.
  • These findings highlight distinct survival signaling mechanisms in trophoblast cells compared to other cell types.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...